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498a Tuesday, March 3, 2009into host tissue. To address functional integration, the physiological interac-
tions between muscle cells and their microenvironment need to be further
elucidated. We are using microfabricated post array detectors (mPADs) as
novel functional assays to assess contractile forces transferred through focal
adhesions to the extracellular environment from cardiomyocytes. mPADs uti-
lize an array of microscale posts that deflect as cantilever springs in response
to forces applied by cells cultured upon them. Contractile forces of neonatal
rat cardiomyocytes (NRCs) are calculated by analyzing the deflection of the
posts and multiplying by their spring constant. The measured forces are com-
pared to vascular smooth muscle cells (VSMCs), cells with similarly disorga-
nized contractile apparatus, and adult rat cardiomyocytes (ARCs). Using im-
munofluorescence of vinculin, both NRCs and VSMCs demonstrate the
ability to create focal adhesions to the fibronectin coatings on the tips of
the posts. Preliminary results indicate that VSMC produced a total force of
570 5 175 nN/cell which is almost 6-fold greater than NRCs. However,
NRCs produce 50% more force per unit area than VSMC. Furthermore, spon-
taneous beating of NRCs yielded an additional maximal contraction of 55.6
nN per post per beat above the baseline which is about two orders of mag-
nitude lower than reported forces produced by ARCs. The use of mPADs
provides a tool to further the understanding of the stress and strains created
by cardiomyocytes onto their local environments through their focal adhe-
sions. With this new technique to assess muscle adhesion and contractility,
we seek to characterize the physiological interactions that implanted muscle
cells must recapitulate to advance new therapies for cardiovascular regener-
ative medicine. HL61683 & UWRRF
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Altered contractility in cardiac myocytes associated with motor protein mu-
tations has been implicated in several pathologies such as familial hypertro-
phic (FHC) and dilated (DCM) cardiomyopathies. The mechanism(s) by
which these altered contractile forces result in cell phenotype changes are
poorly understood. However, they are generally believed to involve mecha-
notransduction of force by cell adhesion molecules such as the integrin class
of proteins. Here we investigate the use of blebbistatin and other small mol-
ecule effectors of actin-myosin mechanochemistry as a chemical model for
the reduced contractile force associated with the pathogenesis of DCM. In
order to establish intercalated-disk cell associations in vitro that are represen-
tative of in vivo conditions, we employ micropatterned cardiac myocyte cell
culture, where the extracellular matrix proteins collagen and laminin are
printed onto the culture vessel surface in 10mm wide lines. Fluorescent
polymer microspheres (0.25mm dia.) are embedded in the collagen layer.
As the beads move from myocyte contraction, the movement amplitude is
measured by nanometer-resolution position analysis, both in the presence
of blebbistatin and in the rescue state where blebbistatin is removed. Relative
force generation is calculated from the position analysis data and matrix
modulus. Cells are then fixed and prepared with fluorescent antibodies for
observation of connexin-43 and b1 integrin expression and localization by
confocal microscopy. By employing micropatterned cardiac myocyte cell cul-
ture, optical contractile force measurement, and subsequent observation of
the expression and localization of connexin-43 and b1 integrin, we assess
the changes in integrin activity due to blebbistatin-induced reduction in
contractile force.
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Molecular mechanisms underlying diastolic suction are poorly understood.
Several proteins have been implicated to play a role, including extra-cellular
proteins, titin, and cytoskeletal proteins. An in vitro measurement of diastolic
suction at the cell level is restoring force (or stiffness), a force which is difficult
to measure as it requires a cell to be passive below the slack sarcomere length
(SL). Previous restoring force studies were made utilizing calcium independent
shortening of cardiomyocytes to below their slack length and then upon relax-
ation measuring the force that developed as the cell is stretched back to its slack
length. However, these studies used chemically permeablized cells and, thus,eliminated the membrane and soluble intracellular proteins as possible contrib-
utors to restoring force. In the current study we developed a novel method to
determine restoring force and the slack sarcomere length of mouse cardiomyo-
cytes that were intact. Intact cardiac myocytes that were below their slack
length due to a low level of active force development were attached to flexible
carbon fibers. We then added butanedione monoxime (BDM) to inhibit actomy-
osin interactions and abolish active tension. This led to an increase in the sar-
comere length and a negative force. From this new baseline force (-1.3450.34
mN/mm2 (mean5SE)), we stretched the cells across the physiological range
from ~1.8-2.2 mm. We determined the sarcomere length at which force is
zero (slack SL) to be 1.9350.019 mm. Plotting the stress-SL relationship we
then determined the restoring stiffness from the slope of this plot as 16.1
mN/mm2/mm. Thus we successfully measured the restoring force - SL relation
of intact cardiac myocytes.
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During postnatal striated muscle development, multiple changes in active and
passive properties occur, reflecting an altered mechanical demand. For in-
stance, during postnatal cardiac development titin isoform expression switches
from large isoforms to small stiffer isoforms, likely affecting diastolic filling
behavior. In the present study, we investigated whether titin isoform transi-
tions also take place during skeletal muscle development. We used gel-elec-
trophoresis to determine changes in titin isoform size in mice and rabbits of
various ages. A titin exon microarray was used to evaluate transcript expres-
sion of all of titin’s exons. To investigate the mechanical effect of titin iso-
form transitions, passive properties of neonatal and adult skeletal muscles
were determined.
Neonatal mice were found to express large titin isoforms, which are gradually
replaced by smaller isoforms during skeletalmuscle development. The half tran-
sition time of the isoform for tibialis cranialis (TC), soleus, extensor digitorum
longus, gastrocnemius and diaphragm were 6, 17, 17, 12, and 10 days, respec-
tively. Essentially similar findingswere obtained fromNZWrabbits,with the ex-
ception that the half-life of the isoform transitions was slightly longer compared
to murine skeletal muscles. Titin exon analysis in neonatal murine gastrocne-
mius muscle revealed increased expression of a large group of exons when com-
pared to adult muscle transcripts, with all upregulated exons coding for exons of
the elastic PEVK region of titin. In line with these observations, we found ~50%
lower titin-based passive stiffness of murine neonatal soleus and TC when com-
pared to adult muscle.These data demonstrate that during skeletal muscle devel-
opment titin isoform transitions occur from large compliant isoforms to smaller
and stiffer isoforms in adult muscle, likely due to changed expression of PEVK
exons.
2570-Pos Board B540
Vinculin Contributes to the Passive Stiffness of Myocardium
Joyce Chuang, Robert Ross, Andrew McCulloch, Jeffrey Omens.
University of California San Diego, La Jolla, CA, USA.
In cardiomyocytes, the costamere links the Z disc to the surrounding extracellu-
lar matrix. Proteins at these junctions include integrins, talin, and vinculin (Vin).
Vin is also found in the intercalated discs. Cardiac-specific Vin knockout
(VinKO) mice have a sudden death phenotype early in life (<12 weeks of
age) with a progressive dilated cardiomyopathy leading to 100% mortality by
32 wks. At 7 weeks of age, systolic ventricular function is normal.
We hypothesize that deletion of the costameric protein Vin leads to changes in
passive stiffness prior to the onset of systolic dysfunction. Vin deletion may
disrupt the normal force transmission pathways from ECM to cytoskeleton
through the integrin-based costamere or cell-to-cell force transmission along
the myocyte axis, which may manifest in altered passive material properties
of the myocardium.
To test the mechanical properties of myocardial tissue, a system was developed
in which murine right ventricular papillary muscles could be passively strained
in the axial direction while simultaneously measuring force. Papillary muscles
from 7 week old VinKO mice and WT controls were isolated and stretched.
Stress-strain analysis was used to measure passive stiffness in the direction
of myocardial fibers.
Stress-strain curves were significantly different between WT and VinKO pap-
illary muscles (p<0.05). The slope of the VinKO curve was less than in the
WT curve, indicating that VinKO muscles are more compliant in the fiber
Tuesday, March 3, 2009 499adirection. This data suggests that Vin contributes to the passive mechanical
properties of the myocardium, and disrupting the mechanical linkage between
the cytoskeleton and the cell membrane reduces the overall stiffness of the
myocardium.
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We have developed a polyclonal antibody specific to skeletal muscle actin
(ACTA1) in the presence of cardiac actin (ACTC) and have used it to quantify
the skeletal actin content of human and mouse cardiac muscle. Heart muscle
myofibrils were separated by SDS-PAGE and Western blotted. The membrane
was stained first with MemCode total protein stain and then probed in with the
anti-skeletal muscle actin antibody, visualised by ECL. The ECL band signal
was normalised to MemCode-stained actin band. Skeletal muscle myofibrils
were used as a 100% skeletal actin standard. For the negative control we used
myofibrils from skeletal muscle of a skeletal actin knockout mouse crossed
with a transgenic mouse over-expressing cardiac actin in skeletal muscle. There
was no detectable signal from the skeletal actin antibody in the pure cardiac actin
control.
Human non-failing donor heart muscle contained 2152% skeletal actin
(n¼9). This is comparable to previous estimates using N-terminal sequencing
or Mass spectroscopy. In both end-stage failing heart muscle and in myec-
tomy samples from HCM muscle the skeletal actin content was much higher
(5855% in both cases, n¼12, 11). The increase in skeletal actin content of
myopathic muscle was highly significant (p< 0.001). Mouse heart muscle
(C57BL/6 strain) contains 2653% skeletal actin (n¼7). This is similar to
human heart. ACTC DCM mutation E361G expressed at 50% in mouse heart
has 1653% (n¼8) skeletal actin but ACTC HCM mutation E99K expressed
at 50% is not significantly different from NTG 2452% (n¼5). We conclude
that in human heart, acquired heart failure or failure secondary to HCM is
associated with an increased content of skeletal muscle actin. In contrast,
in mouse genetic models of HCM and DCM skeletal muscle actin content
may be lower than normal.
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FHC is a primary cardiac muscle disorder that is one of the most common
causes of sudden death in young people. FHC ‘‘hotspot’’ mutations at residue
92 in cardiac troponin T (cTnT) flank the proposed a-helical TNT1 tail domain
whose flexibility has been suggested to be important in normal protein-protein
interactions within the thin filament. Through Molecular Dynamics (MD) sim-
ulations, we showed that FHC mutations Arg92Leu, Arg92Trp, and Arg92Gln
cause local a-helical structural changes and increased flexibility at a critical
hinge region 18 Angstroms distant from the mutation. We have extended this
MD analysis via the use of a self-defined coordinate to measure localized bends
in the helix and found that forces acting on this bending coordinate are lower in
mutants than wildtype. This quantitatively suggests a less restrictive bending
motion in mutants explaining the increased flexibility of the hinge region. To
determine how primary biophysical changes induced by these mutations cause
complex cardiomyopathies we hypothesize that flexibility alterations and
changes in force within compaction-expansion regions in mutational segments
lead to electrostatic perturbations, possibly interfering with cTnT-TM complex
formation and thin filament function. In vitro motility assays with wildtype
cTnT and hotspot FHC-cTnT mutants are in progress to directly correlate pre-
dicted alterations in electrostatic properties with resultant functional changes.
Moreover, contractile and Ca2þ transient measurements on isolated myocytes
address downstream myocellular responses to the mutation’s primary perturba-
tion on structure and function. Data showed normal percent shortening in Ar-
g92Leu myocytes while Arg92Trp percent shortening was significantly im-
paired compared to Non-Tg (4.740 þ 1.165 vs. 6.971 þ 2.098, p<0.001).
Completion of these studies will directly address the links between thin fila-
ment structure/function, downstream myocellular responses, and resultant dis-
tinct cardiovascular phenotypes.2573-Pos Board B543
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Familial Hypertrophic Cardiomyopathy (FHC) is a primary disease of the
cardiac sarcomere. Many disease-causing mutations in the thin filament pro-
tein cTnT are found within the TNT1 region. Residues 160-163 represent
a mutational hotspot within a highly charged region (158-RREEEENRR-
166). In this region, this highly alpha helical domain may unwind to create
a flexible hinge that is necessary for function, the structure and dynamics
of which may be affected by FHC mutations. We are investigating the
structure and function of this region using in vitro motility (IVM) assays
and SDSL-EPR. The purpose of our IVM experiments is two-fold: to func-
tionally analyze our spin labeled proteins and to gain insight into the func-
tion of TNT1 in the presence of cysteine substitutions and FHC mutations.
Preliminary IVM data shows a progressive increase in the severity of the
functional effects of cysteine substitution and spin labeling across the puta-
tive hinge region (153<168<172), suggesting that this region is dynami-
cally important and may be making critical interactions with other compo-
nents of the sarcomere. Preliminary CW-EPR spectra show an increase in
isotropic rotational rate at residue 153 (upstream of the putative hinge re-
gion) between cTnT alone and in the troponin ternary complex, suggesting
that there is a decrease in alpha helical character at this residue in the ter-
nary complex. Introduction of D160E further increases the isotropic rota-
tional rate, suggesting an increase in flexibility due to backbone changes
induced by the mutation. To further investigate structural and functional
changes caused by FHC mutations within the putative hinge region, we
will continue to expand our IVM functional analyses with additional cyste-
ine substitutions, as well as FHC mutations at residues 160 and 163. Dou-
ble label SDSL-EPR are currently underway that will provide secondary
and tertiary structural information.
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Previous studies have shown that MLCK-phosphorylation of the ventricular
regulatory light chain (RLC) increases myofilament Ca2þ sensitivity, maximal
level of force and rate of tension development thereby enhancing the systolic
function of the heart. We have investigated the effect of FHC (familial hyper-
trophic cardiomyopathy) mutations in the myosin RLC on its phosphorylation
measured in rapidly frozen ventricular samples from transgenic (Tg) mice. We
observe that the Aspartate to Valine substitution in Tg-D166V mice and Ar-
ginine to Glutamine in Tg-R58Q mice result in a decreased phosphorylation
of RLC detected in left ventricular samples from Tg-mutant compared to
Tg-WT mice expressing the human ventricular RLC. The level of RLC phos-
phorylation was determined by Western blotting utilizing human specific
phospho-RLC antibodies (gift from Dr. N. Epstein, NIH). Our data from
skinned Tg-D166V and Tg-R58Q papillary muscle fibers show that both
RLC mutations lead to a decreased maximal level of force and to slower ki-
netics of force generating myosin cross-bridges compared to WT fibers. Stud-
ies in intact papillary muscle fibers show prolonged force transients for both
D166V and R58Q mutants. In addition, the hearts of aging mutant mice dem-
onstrate histopathological changes and frequent occurrences of fibrotic le-
sions. Clinical studies revealed that both D166V and R58Q mutations are as-
sociated with severe FHC phenotypes with multiple cases of sudden cardiac
death. Our results suggest that phosphorylation of RLC plays an important
role in regulating cardiac function and its deficit may contribute to malignant
FHC phenotypes. Reduced RLC phosphorylation observed in the D166V and
R58Q hearts correlates with our cellular findings and could be responsible for
delayed force transients, slower cross-bridge kinetics and decreased force ob-
served in Tg-D166V and Tg-R58Q papillary muscle fibers. Supported by
NIH- HL071778 (D.S-C.).
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